FrancophonIA/ELRC3.0 huggingface dataset:
English: Dizziness, sensory disturbances (including paraesthesia), sleep disturbances (including insomnia and intense dreams), agitation or anxiety, nausea and/or vomiting, tremor ,headache, irritability, diarrhoea, hyperhydrosis and vertigo are the most commonly reported reactions.
Slovenian: Reakcije, o katerih najpogosteje poročajo so omotica, senzorične motnje (vključno s parestezijo), motnje spanja (vključno z nespečnostjo in intenzivnimi sanjami), agitacija ali tesnobnost, slabost in/ali bruhanje, tresenje, glavobol, razdražljivost, driska, hiperhidroza in vrtoglavica.
English: However, the concomitant use of DULOXETINE BOEHRINGER INGELHEIM with selective, reversible MAOIs is not recommended (see section 4.4).
Slovenian: Vendar pa sočasno uporabo zdravila DULOKSETIN BOEHRINGER INGELHEIM s selektivnimi reverzibilnimi MAOI odsvetujemo (glejte poglavje 4.4).
English: Do not take more than the daily amount of DULOXETINE BOEHRINGER INGELHEIM that has been prescribed for you in one day.
Slovenian: Ne zaužijte več zdravila DULOKSETIN BOEHRINGER INGELHEIM v enem dnevu, kot vam je bilo predpisano.
English: Therefore DULOXETINE BOEHRINGER INGELHEIM should not be administered in combination with potent inhibitors of CYP1A2 like fluvoxamine (see section 4.3).
Slovenian: Zato zdravila DULOKSETIN BOEHRINGER INGELHEIM ne smemo dajati skupaj z močnimi zaviralci CYP1A2, denimo s fluvoksaminom (glejte poglavje 4.3).
English: Medicinal products metabolised by CYP1A2: The pharmacokinetics of theophylline, a CYP1A2 substrate, were not significantly affected by co-administration with duloxetine (60 mg twice daily).
Slovenian: Zdravila, ki jih presnavlja CYP1A2: sočasno dajanje duloksetina (60 mg dvakrat na dan) ni značilno vplivalo na farmakokinetiko teofilina, substrata CYP1A2.
English: Rare side effects (these can affect from 1 to 10 users in 10,000 patients treated)
Slovenian: Redki neželeni učinki (se lahko pojavijo pri 1 do 10 bolnikov od 10.000 zdravljenih bolnikov)
English: In an open label long-term uncontrolled study, the pain reduction in patients responding to 8-weeks of acute treatment of DULOXETINE BOEHRINGER INGELHEIM 60 mg once daily was maintained for a further 6-months as measured by change on the Brief Pain Inventory (BPI) 24-hour average pain item.
Slovenian: tedensko akutno zdravljenje z zdravilom DULOKSETIN BOEHRINGER INGELHEIM 60 mg enkrat na dan, ohranilo nadaljnjih 6 mesecev (merjeno s spremembo postavke 24-urne povprečne bolečine vprašalnika BPI (Brief Pain Inventory)).
English: Suicide-related behaviours (suicide attempts and suicidal thoughts), and hostility (predominantly aggression, oppositional behaviour and anger), were more frequently observed in clinical trials among children and adolescents treated with antidepressants compared to those treated with placebo.
Slovenian: V kliničnih preskušanjih med otroci in mladostniki, zdravljenimi z antidepresivi, v primerjavi s tistimi, ki so prejemali placebo, so pogosteje opažali s samomorom povezana vedenja (poskusi samomora in samomorilne misli) in sovražnost (zlasti nasilnost, nasprotovalno vedenje in jezo).
English: • depression, anxiety and urinary incontinence.
Slovenian: • depresije, anksioznosti in urinske inkontinence Sočasni uporabi več kot enega od teh zdravil se moramo izogibati.
English: DULOXETINE BOEHRINGER INGELHEIM 60 mg is available in packs of 28 and 98 capsules.
Slovenian: Zdravilo DULOKSETIN BOEHRINGER INGELHEIM 60 mg je na voljo v pakiranjih po 28 in 98 kapsul.
English: Caution is advised if DULOXETINE BOEHRINGER INGELHEIM is co-administered with medicinal products that are predominantly metabolised by CYP2D6 (risperidone, tricyclic antidepressants [TCAs] such as nortriptyline, amitriptyline, and imipramine) particularly if they have a narrow therapeutic index (such as flecainide, propafenone and metoprolol).
Slovenian: Če zdravilo DULOKSETIN BOEHRINGER INGELHEIM dajemo sočasno z zdravili, ki jih presnavlja predvsem CYP2D6 (risperidon, triciklični antidepresivi [tricyclic antidepressants, TCAs], kot so nortriptilin, amitriptilin in imipramin) in zlasti če imajo ozek terapevtski indeks (kot na primer s flekainidom, propafenonom in metoprololom), svetujemo previdnost.
English: • diarrhoea, constipation, being sick (vomiting), heartburn, breaking wind, stomach pain
Slovenian: • driska, zaprtje, bruhanje, pekoča zgaga, vetrovi, bolečina v želodcu
English: Edible green ink: black iron oxide-synthetic (E172), yellow iron oxide- synthetic (E172), propylene glycol, shellac.
Slovenian: Užitno zeleno črnilo: črni železov oksid - sintetični (E172), rumeni železov oksid - sintetični (E172), propilenglikol, šelak.
English: • passing bright red blood in your stools, vomiting blood, or black tarry stools (faeces)
Slovenian: • svetlo rdeče krvavo blato pri odvajanju, bruhanje krvi ali črno blato
English: Hypersensitivity disorder Anaphylactic reaction
Slovenian: Preobčutljivost Anafilaktična reakcija
English: 5 How to store DULOXETINE BOEHRINGER INGELHEIM Further information
Slovenian: 5 Shranjevanje zdravila DULOKSETIN BOEHRINGER INGELHEIM Dodatne informacije
English: Caution should be exercised when using DULOXETINE BOEHRINGER INGELHEIM in combination with antidepressants.
Slovenian: Pri uporabi zdravila DULOKSETIN BOEHRINGER INGELHEIM v kombinaciji z antidepresivi je potrebna previdnost.
English: (See end of Section 2 for further information on sucrose) Capsule shell: gelatin, sodium lauryl sulphate, titanium dioxide (E171), indigo carmine (E132), iron oxide yellow (E172) (60 mg only) and edible green ink (30 mg) or edible white ink (60 mg).
Slovenian: Ovojnica kapsule: želatina, natrijev lavrilsulfat, titanov dioksid (E171), indigotin (E132), rumeni železov oksid (E172) (samo 60 mg) in užitno zeleno črnilo (30 mg) ali užitno belo črnilo (60 mg).
English: DULOXETINE BOEHRINGER INGELHEIM should not be used in patients with liver disease resulting in hepatic impairment (see sections 4.3 and 5.2).
Slovenian: Zdravila DULOKSETIN BOEHRINGER INGELHEIM pri bolnikih z obolenjem jeter, ki ima za posledico okvarjeno delovanje jeter, ne smemo uporabljati (glejte poglavji 4.3 in 5.2).
English: The 60 mg capsules has an opaque green body, imprinted with ‘60 mg' and an opaque blue cap, imprinted with ‘9542'.
Slovenian: 60 mg kapsule imajo neprozorna zelena telesa z vtisnjenim napisom ‘60 mg' in neprozorne modre pokrovčke z vtisnjenim napisom ‘9542'.
English: Weight decrease Weight increase Creatine phosphokinase increased
Slovenian: Povečanje telesne mase Zvišanje kreatininfosfokinaze
English: • bad breath
Slovenian: • slab zadah
English: Dizziness attention Lethargy Dysgeusia Dyskinesia Restless legs syndrome sleep symptoms Akathisia Psychomotor restlessness
Slovenian: Mioklonus Živčnost Motnja pozornosti Letergija Disgevzija Diskinezija Sindrom nemirnih nog Slaba kvaliteta spanja
English: Urine odour abnormal
Slovenian: Nenormalen vonj urina
English: 5Cases of suicidal ideation and suicidal behaviours have been reported during duloxetine therapy or early after treatment discontinuation (see section 4.4)
Slovenian: 5Med zdravljenjem z duloksetinom ali kmalu po prekinitvi zdravljenja so poročali o primerih razmišljanja o samomoru in samomorilnem obnašanju (glejte poglavje 4.4).
English: INFORMATION IN BRAILLE DULOXETINE BOEHRINGER INGELHEIM 60 mg
Slovenian: PODATKI V BRAILLOVI PISAVI DULOKSETIN BOEHRINGER INGELHEIM 60 mg
English: INFORMATION IN BRAILLE DULOXETINE BOEHRINGER INGELHEIM 30 mg
Slovenian: PODATKI V BRAILLOVI PISAVI DULOKSETIN BOEHRINGER INGELHEIM 30 mg
English: Your doctor will tell you if you should be taking DULOXETINE BOEHRINGER INGELHEIM.
Slovenian: Vaš zdravnik vam bo povedal, če smete jemati zdravilo DULOKSETIN BOEHRINGER INGELHEIM.
English: • having abnormal urine odour
Slovenian: • nenormalen vonj urina
English: DULOXETINE BOEHRINGER INGELHEIM gastro-resistant capsules contain sucrose.
Slovenian: DULOKSETIN BOEHRINGER INGELHEIM trde gastrorezistentne kapsule vsebujejo saharozo.
English: Edible Green Ink contains: Black Iron Oxide-Synthetic (E172) Yellow Iron Oxide- Synthetic (E172) Propylene glycol
Slovenian: Užitno zeleno črnilo vsebuje: črni železov oksid - sintetični (E172) rumeni železov oksid - sintetični (E172) propilenglikol šelak
English: There have been reports of bleeding abnormalities, such as ecchymoses, purpura and gastrointestinal haemorrhage with selective serotonin reuptake inhibitors (SSRIs) and serotonin/noradrenaline reuptake inhibitors (SNRIs).
Slovenian: Pri selektivnih zaviralcih prevzema serotonina (selective serotonin reuptake inhibitors, SSRI) in selektivnih zaviralcih prevzema noradrenalina (selective noradrenaline reuptake inhibitors, SNRI) so poročali o nenormalnih krvavitvah, kot so ekhimoze, purpure in krvavitve iz prebavil.
English: Acute liver injury
Slovenian: Akutna okvara jeter
English: Electrocardiograms were obtained from 528 duloxetine-treated and 205 placebo-treated patients with diabetic neuropathic pain in clinical trials lasting up to 13-weeks.
Slovenian: V 8-tedenskih kliničnih preskušanjih so 1139 bolnikom z veliko depresivno epizodo, zdravljenim z duloksetinom, in 777 bolnikom, ki so prejemali placebo ter v do 13-tedenskih kliničnih preskušanjih so 528 bolnikom z bolečino diabetične nevropatije, zdravljenim z duloksetinom, in 205 bolnikom, ki so prejemali placebo, napravili elektrokardiograme.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 60 mg of duloxetine (as hydrochloride).
Slovenian: KAKOVOSTNA IN KOLIČINSKA SESTAVA Ena kapsula vsebuje 60 mg duloksetina (v obliki klorida).
English: NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER Boehringer Ingelheim International GmbH, Binger Str. 173 D-55216 Ingelheim am Rhein, Germany.
Slovenian: IME IN NASLOV IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM Boehringer Ingelheim International GmbH, Binger Str. 173 D-55216 Ingelheim am Rhein, Nemčija
English: Caution is advisable if DULOXETINE BOEHRINGER INGELHEIM is used concomitantly with serotonergic antidepressants like SSRIs, tricyclics like clomipramine or amitriptyline, St John's wort (Hypericum perforatum), venlafaxine or triptans, tramadol, pethidine and tryptophan.
Slovenian: Če zdravilo DULOKSETIN BOEHRINGER INGELHEIM uporabljamo sočasno s serotonergičnimi antidepresivi, kot so SSRI, tricikličnimi antidepresivi, denimo, klomipraminom ali amitriptilinom, šentjanževko (Hypericum perforatum), venlafaksinom ali triptani, tramadolom, petidinom in triptofanom, priporočamo previdnost.
English: please tell your doctor or pharmacist
Slovenian: Posvetujte se z zdravnikom ali s farmacevtom.
English: MARKETING AUTHORISATION HOLDER Boehringer Ingelheim International GmbH, Binger Str. 173 D-55216 Ingelheim am Rhein, Germany.
Slovenian: IMETNIK DOVOLJENJA ZA PROMET Boehringer Ingelheim International GmbH, Binger Str. 173 D-55216 Ingelheim am Rhein, Nemčija.
English: Gastrointestinal haemorrhage
Slovenian: Gastrointestina lna krvavitev
English: What DULOXETINE BOEHRINGER INGELHEIM looks like and contents of the pack DULOXETINE BOEHRINGER INGELHEIM is a hard gastro-resistant capsule Each capsule of DULOXETINE BOEHRINGER INGELHEIM contains pellets of duloxetine hydrochloride with a covering to protect them from stomach acid.
Slovenian: Vsaka kapsula zdravila DULOKSETIN BOEHRINGER INGELHEIM vsebuje pelete duloksetinijevega klorida z oblogo za zaščito pred želodčno kislino.
English: Also, you need to wait at least 5 days after you stop taking DULOXETINE BOEHRINGER INGELHEIM before you take a MAOI.
Slovenian: Tudi po prenehanju jemanja zdravila DULOKSETIN BOEHRINGER INGELHEIM morate počakati vsaj 5 dni, preden lahko vzamete MAOI.
English: Based on the half-life of duloxetine, at least 5 days should be allowed after stopping DULOXETINE BOEHRINGER INGELHEIM before starting an MAOI (see section 4.3).
Slovenian: DULOKSETIN BOEHRINGER INGELHEIM preteči vsaj 5 dni pred začetkom jemanja MAOI (glejte poglavje 4.3).
English: Ear and Labyrinth Disorders Tinnitus1
Slovenian: Ušesne bolezni, vključno z motnjami labirinta Tinitus1
English: Edible White Ink contains: Titanium Dioxide (E171) Propylene glycol Shellac
Slovenian: Užitno belo črnilo vsebuje: titanov dioksid (E171) propilenglikol šelak povidon
English: • decreased thyroid gland activity
Slovenian: • zmanjšana aktivnost žleze ščitnice
English: Very common side effects (these can affect more than 10 in 100 patients treated)
Slovenian: Pogosti neželeni učinki (se lahko pojavijo pri 1 do 10 bolnikov od 100 zdravljenih bolnikov)
English: MARKETING AUTHORISATION NUMBER(S) EU/1/08/471/003-005
Slovenian: ŠTEVILKA (ŠTEVILKE) DOVOLJENJA (DOVOLJENJ) ZA PROMET EU/1/08/471/003-005
English: Urinary Retention Dysuria Urinary hesitation Nocturia Polyuria Urine flow decreased
Slovenian: Zastajanje seča Disurija Odlašanje uriniranja Nokturija Poliurija Slabši curek urina
English: Hypothyroidism
Slovenian: Hipotiroidize m
English: Concomitant use of DULOXETINE BOEHRINGER INGELHEIM with nonselective, irreversible Monoamine Oxidase Inhibitors (MAOIs) is contraindicated (see section 4.5).
Slovenian: Zdravila DULOKSETIN BOEHRINGER INGELHEIM ne smemo uporabljati sočasno z neselektivnimi ireverzibilnimi zaviralci monoaminooksidaze - MAOI (glejte poglavje 4.5).
English: Other possible side effects
Slovenian: Drugi neželeni učinki
English: PACKAGE LEAFLET: INFORMATION FOR THE USER DULOXETINE BOEHRINGER INGELHEIM 30 mg hard gastro-resistant capsules DULOXETINE BOEHRINGER INGELHEIM 60 mg hard gastro-resistant capsules Duloxetine (as hydrochloride)
Slovenian: NAVODILO ZA UPORABO DULOKSETIN BOEHRINGER INGELHEIM 30 mg trde gastrorezistentne kapsule DULOKSETIN BOEHRINGER INGELHEIM 60 mg trde gastrorezistentne kapsule duloksetin (v obliki klorida)
English: What DULOXETINE BOEHRINGER INGELHEIM contains The active substance is duloxetine.
Slovenian: Kaj vsebuje zdravilo DULOKSETIN BOEHRINGER INGELHEIM Zdravilna učinkovina je duloksetin.
English: Hard gastro-resistant capsule.
Slovenian: FARMACEVTSKA OBLIKA trde gastrorezistentne kapsule
English: • throat inflammation
Slovenian: • vnetje grla
English: These symptoms are usually not serious and disappear within a few days, but if you have symptoms that are troublesome you should ask your doctor for advice.
Slovenian: tresenje, glavoboli, občutek razdraženosti, driska, prekomerno znojenje ali vrtoglavica Ti simptomi običajno niso resni in v nekaj dneh izzvenijo, vendar se posvetujte s svojim zdravnikom, če imate simptome, ki vam povzročajo težave.
English: • lack of appetite, weight loss
Slovenian: • več zehanja • zmanjšanje apetita, zmanjšanje telesne mase
English: Elevated liver enzymes (ALT, AST, alkaline phosphatase) Hepatitis3
Slovenian: AST, alkalna fosfataza)
English: Sodium Lauryl Sulfate Titanium Dioxide (E171) Indigo Carmine (E132) Yellow Iron Oxide (E172) Edible White Ink
Slovenian: 60 mg: želatina natrijev lavrilsulfat titanov dioksid (E171) indigotin (E132) rumeni železov oksid (E172) užitno belo črnilo
English: • muscle pain, muscle tightness, muscle spasm
Slovenian: • mišična bolečina, mišična napetost, mišični krč
English: MARKETING AUTHORISATION NUMBER(S) EU/1/08/471/011-012
Slovenian: ŠTEVILKA (ŠTEVILKE) DOVOLJENJA (DOVOLJENJ) ZA PROMET EU/1/08/471/011-012
English: Marketing Authorisation Holder and Manufacturer Marketing Authorisation Holder: Boehringer Ingelheim International GmbH, Binger Str. 173 D-55216 Ingelheim am Rhein, Germany.
Slovenian: Imetnik dovoljenja za promet z zdravilom: Boehringer Ingelheim International GmbH, Binger Str. 173 D-55216 Ingelheim am Rhein, Nemčija.
English: inability to sleep), feeling restless or agitated, feeling anxious, feeling sick (nausea) or being sick (vomiting), tremor (shakiness), headaches, feeling irritable, diarrhoea, excessive sweating or vertigo.
Slovenian: nezmožnost spanja), občutek nemira ali razburjenosti, občutek strahu, slabost ali bruhanje,
English: Sleep disorder Bruxism
Slovenian: Motnje spanja Bruksizem Dezorientacija Apatija
English: Lilly S.A.
Slovenian: Lilly SA
English: It may harm them, even if their symptoms are the same as yours - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet,
Slovenian: Njim bi lahko celo škodovalo, čeprav imajo znake bolezni, podobne vašim.
English: • vertigo, ear pain
Slovenian: • vrtoglavica, ušesna bolečina
English: Undesirable effects may be more common during concomitant use of DULOXETINE BOEHRINGER INGELHEIM and herbal preparations containing St John's wort (Hypericum perforatum).
Slovenian: Ob sočasni uporabi zdravila DULOKSETIN BOEHRINGER INGELHEIM in pripravkov rastlinskega izvora, ki vsebujejo šentjanževko (Hypericum perforatum), so lahko neželeni učinki pogostejši.
English: Duloxetine is very weakly excreted into human milk based on a study of 6 lactating patients, who did not breast feed their children .
Slovenian: Na osnovi študije 6 doječih bolnic, ki niso dojile svojih otrok, se duloksetin zelo slabo izloča v materino mleko.
English: PHARMACEUTICAL FORM AND CONTENTS 28, hard gastro-resistant capsules 98, hard gastro-resistant capsules.
Slovenian: FARMACEVTSKA OBLIKA IN VSEBINA 28 trdih gastrorezistentnih kapsul
English: − have severe kidney disease are taking or have recently taken within the last 14 days, another antidepressant medicine called a monoamine oxidase inhibitor (MAOI) (see also below in section: ‘Taking other medicines')
Slovenian: - jemljete ali ste v zadnjih 14 dneh jemali drugo antidepresivno zdravilo, imenovano zaviralec monoaminooksidaze (MAOI) (glejte tudi v nadaljevanju v poglavju ‘Jemanje drugih zdravil') - imate obolenje jeter - imate hudo obolenje ledvic - jemljete fluvoksamin, ki se običajno uporablja za zdravljenje depresije, ciprofloksacin ali enoksacin, ki se uporablja za zdravljenje nekaterih okužb Pogovorite se s svojim zdravnikom, če imate nenadzorovan visok krvni tlak.
English: • restless legs syndrome
Slovenian: • sindrom nemirnih nog
English: Psychiatric Disorders Insomnia
Slovenian: Psihiatrične motnje Nespečnost Agitacija
English: Vertigo Ear pain Respiratory, thoracic and mediastinal disorders Yawning
Slovenian: Bolezni dihal, prsnega koša in mediastinalnega prostora Zehanje
English: Chest pain
Slovenian: Suha usta
English: Care should be taken if you drink alcohol while you are being treated with DULOXETINE BOEHRINGER INGELHEIM.
Slovenian: Bodite posebej previdni, če med zdravljenjem z zdravilom DULOKSETIN BOEHRINGER INGELHEIM pijete alkohol.
English: DULOXETINE BOEHRINGER INGELHEIM is for oral use.
Slovenian: Zdravilo DULOKSETIN BOEHRINGER INGELHEIM jemljemo peroralno.
English: Muscle twitching
Slovenian: Napetost mišic
English: − have liver disease
Slovenian: Žilne bolezni
English: The following are reasons why DULOXETINE BOEHRINGER INGELHEIM may not be suitable for you.
Slovenian: Bodite posebno pozorni pri jemanju zdravila DULOKSETIN BOEHRINGER INGELHEIM Spodaj so našteti razlogi, zaradi katerih morda zdravilo DULOKSETIN BOEHRINGER INGELHEIM za vas ni ustrezno.
English: MARKETING AUTHORISATION NUMBER(S) EU/1/08/471/011
Slovenian: ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/08/471/011
English: Ejaculation disorder Ejaculation delayed Sexual
Slovenian: Motnje ejakulacije Zapoznela ejakulacija Seksualna disfunkcija Ginekološka krvavitev
English: Blurred vision Mydriasis Visual disturbance
Slovenian: Zamegljen vid Midriaza Motnje vida
English: Metabolism and Nutrition Disorders Decreased
Slovenian: Presnovne in prehranske motnje Zmanjšanje apetita
English: NAME OF THE MEDICINAL PRODUCT DULOXETINE BOEHRINGER INGELHEIM 30 mg hard gastro-resistant capsules
Slovenian: IME ZDRAVILA DULOKSETIN BOEHRINGER INGELHEIM 30 mg trde gastrorezistentne kapsule
English: Hyponatremia has been reported rarely, predominantly in the elderly, when administering DULOXETINE BOEHRINGER INGELHEIM.
Slovenian: Ob dajanju zdravila DULOKSETIN BOEHRINGER INGELHEIM so redko poročali o hiponatremiji, zlasti pri starejših.
English: NAME OF THE MEDICINAL PRODUCT DULOXETINE BOEHRINGER INGELHEIM 60 mg hard gastro-resistant capsules
Slovenian: IME ZDRAVILA DULOKSETIN BOEHRINGER INGELHEIM 60 mg trde gastrorezistentne kapsule
English: MARKETING AUTHORISATION NUMBER(S) EU/1/08/471/003
Slovenian: ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/08/471/003
English: Sodium Lauryl Sulfate Titanium Dioxide (E171) Indigo Carmine (E132) Edible Green Ink
Slovenian: Ovojnica kapsule: 30 mg: želatina natrijev lavrilsulfat titanov dioksid (E171) indigotin (E132) užitno zeleno črnilo
English: DULOXETINE BOEHRINGER INGELHEIM contains sucrose.
Slovenian: Zdravilo DULOKSETIN BOEHRINGER INGELHEIM vsebuje saharozo.
English: BEFORE YOU TAKE DULOXETINE BOEHRINGER INGELHEIM
Slovenian: KAJ MORATE VEDETI, PREDEN BOSTE VZELI ZDRAVILO DULOKSETIN BOEHRINGER INGELHEIM
English: The use of DULOXETINE BOEHRINGER INGELHEIM while breastfeeding is not recommended.
Slovenian: • dojiteUporabo zdravila DULOKSETIN BOEHRINGER INGELHEIM v času dojenja odsvetujemo.
English: • fits
Slovenian: • krči
English: Feeling hot Gait disturbance
Slovenian: Mrzlica Bolehnost Občutek vročine
English: Malaise
Slovenian: Vrtoglavica
English: Vascular Disorders Flushing
Slovenian: Okvarjeno delovanje jeter
English: THE MARKETING AUTHORISATION HOLDER Medicinal product subject to medical prescription
Slovenian: Imetnik dovoljenja za promet z zdravilom in izdelovalec:
English: HOW TO STORE DULOXETINE BOEHRINGER INGELHEIM Keep out of the reach and sight of children
Slovenian: SHRANJEVANJE ZDRAVILA DULOKSETIN BOEHRINGER INGELHEIM Zdravilo shranjujte nedosegljivo otrokom!
English: You may need to read it again - If you have any further questions, ask your doctor or pharmacist - This medicine has been prescribed for you.
Slovenian: - Če imate dodatna vprašanja, se posvetujte z zdravnikom ali s farmacevtom.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each capsule contains 30 mg of duloxetine (as hydrochloride)
Slovenian: NAVEDBA ENE ALI VEČ ZDRAVILNIH UČINKOVIN Ena kapsula vsebuje 30 mg duloksetina (v obliki klorida).
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each capsule contains 60 mg of duloxetine (as hydrochloride)
Slovenian: NAVEDBA ENE ALI VEČ ZDRAVILNIH UČINKOVIN Ena kapsula vsebuje 60 mg duloksetina (v obliki klorida).
English: Serotonin syndrome
Slovenian: Serotoninski sindrom Ekstrapiramid ni simptomiAkati zija
English: − are allergic (hypersensitive) to duloxetine or any of the other ingredients of DULOXETINE BOEHRINGER INGELHEIM
Slovenian: NE jemljite zdravila DULOKSETIN BOEHRINGER INGELHEIM, če: - ste alergični (preobčutljivi) na duloksetin ali katerokoli drugo sestavino zdravila DULOKSETIN
English: Information from clinical trials has shown an increased risk of suicidal behaviour in adults aged less than 25 years with psychiatric conditions who were treated with an antidepressant.
Slovenian: (mlajših od 25 let) z motnjami razpoloženja med zdravljenjem z antidepresivi obstaja večje tveganje za pojav samomorilnega vedenja.
English: DULOXETINE BOEHRINGER INGELHEIM may make you feel sleepy of dizzy.
Slovenian: Vpliv na sposobnost upravljanja vozil in strojev Zdravilo DULOKSETIN BOEHRINGER INGELHEIM lahko vpliva, da se počutite zaspani ali omotični.
English: NAME OF THE MEDICINAL PRODUCT DULOXETINE BOEHRINGER INGELHEIM 30 mg hard gastro-resistant capsules Duloxetine
Slovenian: DULOKSETIN BOEHRINGER INGELHEIM 30 mg trde gastrorezistentne kapsule duloksetin
English: Hypromellose.
Slovenian: Dehidracija Hiponatriemija
English: NAME OF THE MEDICINAL PRODUCT DULOXETINE BOEHRINGER INGELHEIM 60 mg hard gastro-resistant capsules Duloxetine
Slovenian: DULOKSETIN BOEHRINGER INGELHEIM 60 mg trde gastrorezistentne kapsule duloksetin
English: Boehringer Ingelheim Pharma GmbH & Co. KG Tel: +49 (0) 69 50 50 83 09
Slovenian: KG Tel: +49 (0) 69 50 50 83 09
English: Breast feeding
Slovenian: • zvečanje telesne mase
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS 60 mg hard gastro-resistant capsules
Slovenian: 60 mg trde gastrorezistentne kapsule
English: The main measure of effectiveness is the number of patients who respond to treatment.
Slovenian: Glavno merilo učinkovitosti je število bolnikov, ki se odzovejo na zdravljenje.
English: It was to be available as tablets (125 mg and 250 mg).
Slovenian: Na voljo naj bi bilo v obliki tablet (125 mg in 250 mg).
English: EGFR controls growth and division of cells.
Slovenian: EGFR nadzoruje rast in delitev celic.